XRAY - DENTSPLY SIRONA Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $0.28
|
Rev Est: $926.4M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$13.33
DETAILS
HIGH:
$16.00
LOW:
$12.00
MEDIAN:
$13.00
CONSENSUS:
$13.33
UPSIDE:
1.45%
Market Cap:
2.62B
Volume:
5,423,594
Avg Volume:
4,024,166
52 Week Range:
9.85-19.27
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
1.02
Last Dividend:
$0.64
Exchange:
NASDAQ
Country:
US
Employees:
14,000
IPO Date:
1987-08-12
EPS (TTM):
-4.48
P/E Ratio:
-4.24
Revenue (TTM):
3.79B
Total Assets:
5.75B
Total Debt:
2.27B
Cash & Equiv:
272.00M
Rev Growth (5Y):
-1.2%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
-11.2%
ROCE:
-20.8%
Debt/Equity:
1.17
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $0.37 | $0.45 | -17.8% | $904.0M | $927.1M | -2.5% |
| 2025-08-07 | $0.52 | $0.50 | +4.0% | $936.0M | $904.6M | +3.5% |
| 2025-05-08 | $0.43 | $0.29 | +48.3% | $879.0M | $920.2M | -4.5% |
| 2025-02-27 | $0.26 | $0.47 | -44.7% | $905.0M | $901.3M | +0.4% |
| 2024-11-07 | $0.50 | $0.48 | +4.2% | $951.0M | $937.0M | +1.5% |
| 2024-07-31 | $0.49 | $0.50 | -2.0% | $984.0M | $995.7M | -1.2% |
| 2024-05-02 | $0.42 | $0.42 | 0.0% | $953.0M | $969.1M | -1.7% |
| 2024-02-29 | $0.44 | $0.43 | +2.3% | $1.0B | $976.9M | +3.6% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.79B | 3.96B | 3.92B | 4.23B | 3.34B | 4.02B | 3.99B | 3.99B | 3.75B | 2.67B | 2.92B | 2.95B |
| Net Income | (910.00M) | (132.00M) | (950.00M) | 411.00M | (73.00M) | 256.00M | (1.01B) | (1.55B) | 429.90M | 251.20M | 322.85M | 313.19M |
| EPS | -4.48 | -0.62 | -4.41 | 1.88 | -0.38 | 1.18 | -4.51 | -6.86 | 1.97 | 1.79 | 2.28 | 2.20 |
| Total Assets | 5.75B | 7.37B | 7.64B | 9.24B | 9.35B | 8.60B | 8.69B | 10.38B | 11.66B | 4.40B | 4.65B | 5.08B |
| Total Debt | 2.27B | 2.30B | 2.15B | 2.29B | 2.46B | 1.60B | 1.66B | 1.61B | 1.51B | 1.14B | 1.15B | 1.17B |
| Cash & Equivalents | 272.00M | 334.00M | 365.00M | 339.00M | 438.00M | 405.00M | 309.60M | 320.60M | 383.90M | 284.60M | 151.64M | 74.95M |
| Operating Cash Flow | 461.00M | 377.00M | 517.00M | 657.00M | 649.00M | 632.80M | 499.80M | 601.90M | 563.40M | 497.40M | 560.40M | 417.85M |
| Free Cash Flow | 281.00M | 228.00M | 368.00M | 515.00M | 562.00M | 509.90M | 311.80M | 450.90M | 437.30M | 425.40M | 454.63M | 316.43M |
| FCF per Share | 1.38 | 1.08 | 1.71 | 2.36 | 2.56 | 2.29 | 1.39 | 1.97 | 2.01 | 3.04 | 3.21 | 2.22 |
| Book Value | 1.94B | 3.29B | 3.81B | 5.00B | 4.93B | 5.09B | 5.12B | 6.63B | 8.11B | 2.34B | 2.32B | 2.54B |
| Cash & ST Investments | 272.00M | 334.00M | 365.00M | 339.00M | 438.00M | 405.00M | 309.60M | 320.60M | 383.90M | 284.60M | 151.64M | 74.95M |
| ROC Equity | -0.47 | -0.04 | -0.25 | 0.08 | -0.01 | 0.05 | -0.20 | -0.23 | 0.05 | 0.11 | 0.14 | 0.12 |